Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:646-653
Published online before print February 23, 2009, doi: 10.1161/HYPERTENSIONAHA.108.123455
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Hypertension: April 2009,Volume 53, Number 4
Right arrow All Versions of this Article:
53/4/646    most recent
HYPERTENSIONAHA.108.123455v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feldman, R. D.
Right arrow Articles by Feagan, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feldman, R. D.
Right arrow Articles by Feagan, B. G.
Related Collections
Right arrow Compliance/Adherence
Right arrow Clinical Studies
Right arrow Other Treatment
Right arrowRelated Article

(Hypertension. 2009;53:646.)
© 2009 American Heart Association, Inc.


Original Articles

A Simplified Approach to the Treatment of Uncomplicated Hypertension

A Cluster Randomized, Controlled Trial

Ross D. Feldman; Guang Y. Zou; Margaret K. Vandervoort; Cindy J. Wong; Sigrid A.E. Nelson; Brian G. Feagan

From the Robarts Clinical Trials (R.D.F., G.Y.Z., M.K.V., C.J.W., S.A.E.N., B.G.F.), Robarts Research Institute, London, Ontario, Canada; Schulich School of Medicine and Dentistry, Department of Medicine (R.D.F., B.G.F.), Department of Physiology and Pharmacology (R.D.F.), and Department of Epidemiology and Biostatistics (G.Y.Z., B.G.F.), University of Western Ontario, London, Ontario, Canada.

Correspondence to Ross D. Feldman, Robarts Research Institute, 100 Perth Dr, London, Ontario N6A 5K8, Canada. E-mail Ross.Feldman{at}lhsc.on.ca

Notwithstanding the availability of antihypertensive drugs and practice guidelines, blood pressure control remains suboptimal. The complexity of current treatment guidelines may contribute to this problem. To determine whether a simplified treatment algorithm is more effective than guideline-based management, we studied 45 family practices in southwestern Ontario, Canada, using a cluster randomization trial comparing the simplified treatment algorithm with the Canadian Hypertension Education Program guidelines. The simplified treatment algorithm consisted of the following: (1) initial therapy with a low-dose angiotensin-converting enzyme inhibitor/diuretic or angiotensin receptor blocker/diuretic combination; (2) up-titration of combination therapy to the highest dose; (3) addition of a calcium channel blocker and up-titration; and (4) addition of a non—first-line antihypertensive agent. The proportion of patients treated to target blood pressure (systolic blood pressure <140 mm Hg and diastolic blood pressure <90 mm Hg for patients without diabetes mellitus or systolic blood pressure <130 mm Hg and diastolic blood pressure <80 mm Hg for diabetic patients) at 6 months was analyzed at the practice level. The proportion of patients achieving target was significantly higher in the intervention group (64.7% versus 52.7%; absolute difference: 12.0%; 95% CI: 1.5% to 22.4%; P=0.026). Multivariate analysis of patient-level data showed that assignment to the intervention arm increased the chance of reaching the target by 20% (P=0.028), when adjusted for other covariates. In conclusion, the Simplified Treatment Intervention to Control Hypertension Study indicates that a simplified antihypertensive algorithm using initial low-dose fixed-dose combination therapy is superior to guideline-based practice for the management of hypertension.


Key Words: hypertension management • randomized, controlled trial • fixed-dose combination therapy • cluster randomization • hypertension


Related Article:

Fixed-Dose Combinations and Hypertension Control in Community-Based Practices: Application of the "Keep-It-Simple" Principle
Brent M. Egan
Hypertension 2009 53: 598-599. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
B. Williams
The Year in Hypertension
J. Am. Coll. Cardiol., January 5, 2010; 55(1): 65 - 73.
[Full Text] [PDF]


Home page
HypertensionHome page
D. A. Calhoun, Y. Lacourciere, Y. T. Chiang, and R. D. Glazer
Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide: A Randomized Clinical Trial
Hypertension, July 1, 2009; 54(1): 32 - 39.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. M. Egan
Fixed-Dose Combinations and Hypertension Control in Community-Based Practices: Application of the "Keep-It-Simple" Principle
Hypertension, April 1, 2009; 53(4): 598 - 599.
[Full Text] [PDF]